|
|
 |
|
Viewing report
|
|
|
|
Barr Pharmaceuticals Busintell Report
Knowledge Source Inc., March 2006
Barr Pharmaceuticals is a specialty pharmaceutical company that develops, markets and sells both generic and proprietary (or branded) pharmaceutical products. Barr Pharmaceuticals has a deep, diverse and profitable generic product portfolio, and has diversified its operations by developing and acquiring several proprietary products. For the fiscal year ended June 30, 2005, Barr Pharmaceuticals recorded net earnings of $215 million on revenues of $1 billion. Of its $1 billion of revenues in fiscal 2005, $751 million were from sales of generic products, $279 million were from sales of proprietary products, and $17 million were attributed to revenues derived from co-promotion alliances, development agreements and other sources. Barr Pharmaceutical's business has two reportable segments: generic pharmaceuticals and proprietary pharmaceuticals. In the generic pharmaceutical segment, it currently manufactures and distributes more than 150 different dosage forms and strengths of over 75 different generic pharmaceutical products, including 22 oral contraceptive products, representing the largest category of its generic product portfolio.
Customers who bought this item also bought
Barr Pharmaceuticals Inc.: PharmaVitae Model
Barr Pharmaceuticals - SWOT Analysis - SWOT Analysis
Generic Pharmaceuticals Business Intelligence Report
The World Generic Market Report 2008
Barr Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
U.S. Generic Pharmaceuticals Outlook
Barr Pharmaceuticals Generics Company Intelligence Report
Barr: PharmaVitae Generics Profile
Emerging Opportunities in Controlled-Release Generic Drugs
Emerging Generic Pharmaceuticals Markets in Europe
Emerging Generic Drug Markets in Europe
Generic Strategies in Emerging Markets
|
|
|
|
